Discontinued — last reported Q2 '23

Investing

Acquisitions

Year-over-year, this metric grew by 100.0%, from -$21.00M to $0.00. Over 2 years (FY 2021 to FY 2023), Acquisitions shows a downward trend with a -100.0% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2016
Last reportedQ2 2023

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q4 '24Q1 '25Q4 '25Q1 '26
Value$104.00M$225.00M$415.00M$35.00M$0.00$1.62B$0.00$0.00$0.00$0.00$0.00$8.00M-$21.00M$0.00$0.00
QoQ Change+116.3%+84.4%-91.6%-100.0%-100.0%-362.5%+100.0%
YoY Change-100.0%+620.0%-100.0%-100.0%-100.0%-100.0%+100.0%
Range-$21.00M$1.62B
CAGR-100.0%
Avg YoY Growth+31.4%
Median YoY Growth-100.0%
Current Streak2 quarters growth

Frequently Asked Questions

What is Becton, Dickinson and Company's acquisitions?
Becton, Dickinson and Company (BDX) reported acquisitions of $0.00 in Q1 2026.
How has Becton, Dickinson and Company's acquisitions changed year-over-year?
Becton, Dickinson and Company's acquisitions increased by 100.0% year-over-year, from -$21.00M to $0.00.
What is the long-term trend for Becton, Dickinson and Company's acquisitions?
Over 2 years (2021 to 2023), Becton, Dickinson and Company's acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $508.00M to $0.00.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.